|
31 Jan 2007 |
Exelixis Files IND Application for XL418
|
|
31 Jan 2007 |
First Subjects Dosed in Phase l Trial of Triple Action Agent Tyrima
|
|
31 Jan 2007 |
Debiopharm Signs R&D And Commercialisation Agreement With Kirin For The Development Of DEBIO-0719 In Oncology
|
|
31 Jan 2007 |
Immtech Completes Enrollment in Phase III Pivotal Trial of Pafuramidine for African Sleeping Sickness
|
|
31 Jan 2007 |
Innovative Long-Acting Contraceptive Product Mirena(R) approved in Japan
|
|
31 Jan 2007 |
Proton Pump Inhibitor Pariet(R) Tablets 10mg Receives Approval in Japan
|
|
31 Jan 2007 |
Lexicon Advances LX6171 for Cognitive Disorders into Phase 1b Clinical Trial
|
|
31 Jan 2007 |
Vistagen's AV-101 Drug Candidate Yields Positive Preclinical Data For Neuropathic Pain Applications
|
|
31 Jan 2007 |
YM Biosciences Announces Termination Of The Tesmilifene Phase III Pivotal Trial In Advanced Breast Cancer
|
|
31 Jan 2007 |
FDA approves Neuren's phase 3 Glypromate trial
|
|
31 Jan 2007 |
AVANIR Receives FDA Approvable Letter for New Formulation of Currently Marketed Antipsychotic Drug FazaClo
|
|
31 Jan 2007 |
Santhera Updates Development Strategy for SNT-MC17/idebenone in Friedreich's Ataxia in the US
|
|
30 Jan 2007 |
Tarceva : European approval for pancreatic cancer treatment
|
|
30 Jan 2007 |
Sunesis Pharmaceuticals Reports Positive Initial Results From Phase 2 Small Cell Lung Cancer Trial With SNS-595
|
|
30 Jan 2007 |
Inflazyme Pharmaceuticals Announces Preliminary Outcome of the Phase 2b CAPSICS Asthma Trial
|
|
30 Jan 2007 |
Pharmion Corporation Announces FDA Approval of Vidaza NDA Supplement for IV Administration
|
|
30 Jan 2007 |
New indication for YAZ(R) approved in the U.S.
|
|
30 Jan 2007 |
Threshold Pharmaceuticals Initiates Phase 2 Clinical Trial Evaluating Glufosfamide In Patients With Platinum-Resistant Ovarian Cancer
|
|
27 Jan 2007 |
Oral formulation of Fludara(R) approved in Japan
|
|
27 Jan 2007 |
Antiviral Agent Copegus(R) Tablet 200 mg Received Approval as a Combination Therapy with Chronic Hepatitis C Treatment Drug Pegasys
|
|
27 Jan 2007 |
Approval for Candin Antifungal Agent Funguard for Prophylaxis of Aspergillus and Candida infections in patients undergoing HSCT and Immunosuppressant Prograf for Lupus Nephritis in Japan
|
|
27 Jan 2007 |
AEterna Zentaris Discloses New In Vivo Data for ZEN-012 at the 7th Joint Conference of the AACR and JCA
|
|
26 Jan 2007 |
Biocryst Initiates Phase II Influenza Clinical Trial To Evaluate Peramivir
|
|
26 Jan 2007 |
European Medicines Agency Adopts Positive Opinion Recommending Approval of Xyrem(R) for the Treatment of Narcolepsy with Cataplexy in Adult Patients
|
|
26 Jan 2007 |
JANUVIA(TM), First in New Class of Oral Treatments Known as DPP-4 Inhibitors, Recommended for Approval for the Treatment of Type 2 Diabetes in the European Union
|
